
SINCE 2001
Becoming a trustworthy manufacturer and service supplier of medical equipment
Nanjing Shuangwei was established in 2001, putting forth effort to two main businesses which are Safe Blood Transfusion and Wound Therapy, developing three platforms involving Sterilization Service Platform, Medical Device Agent Platform, New Material R&D And Manufacturing Platform. We focuses on the R&D, production, sales and service of advanced medical devices.
Scale
Patents
Countries
Subsidiaries
Products
Wound Therapy
● Fiberglass Casting Tape
● Fiberglass Casting Splint
● High-vacuum Wound Drainage System
● Portable Negative Pressure Wound Therapy Device
● Polyurethane Negative Pressure Wound Therapy Kit
Products
Safe Blood Transfusion
● Leukocyte Reduction Filter
● Leukocyte Reduction Filter (In-line Filter)
● Disposable Set for Pathogen Inactivation of Plasma
● Blood Tube Stripper
● Semi-Automatic Blood Component Extractor
● Disposable Set for Pathogen Inactivation of Plasma
Urology and Anesthesia
● Disposable Adjustable Endotracheal Tube
● Disposable Prostate Expansion Catheter
● Disposable Closed Suction System
Products
Wound Therapy
● Fiberglass Casting Tape
● Fiberglass Casting Splint
● High-vacuum Wound Drainage System
● Portable Negative Pressure Wound Therapy Device
● Polyurethane Negative Pressure Wound Therapy Kit
Products
Safe Blood Transfusion
● Leukocyte Reduction Filter
● Leukocyte Reduction Filter (In-line Filter)
● Disposable Set for Pathogen Inactivation of Plasma
● Blood Tube Stripper
● Semi-Automatic Blood Component Extractor
● Disposable Set for Pathogen Inactivation of Plasma
Urology and Anesthesia
● Disposable Adjustable Endotracheal Tube
● Disposable Prostate Expansion Catheter
● Disposable Closed Suction System
News Center

Jun 25,2025
Clinical Case 2 : Portable Negative Pressure Wound Therapy Device

Jun 17,2025
Clinical Case 1: Portable Negative Pressure Wound Therapy Device
Jun 13,2025
PRP---Start the Body's Repair Engine
Jun 04,2025
2025ISBT——Shuangwei Biotechnology joins hands with the global community to build a new future of transfusion safety